US · Healthcare

Windtree Therapeutics Inc (WINT)

Biotechnology

Windtree Therapeutics Inc (WINT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for WINT

P/E ratio

18.00

Windtree Therapeutics Inc (WINT) — FAQ

What is WINT's P/E ratio?

The price-to-earnings (P/E) ratio for Windtree Therapeutics Inc (WINT) is 18.00 (data as of 2026-03-24).

Does Windtree Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Windtree Therapeutics Inc (WINT). Check the MyAverix Finance app for the latest dividend data.

What sector is Windtree Therapeutics Inc in?

Windtree Therapeutics Inc (WINT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is WINT listed on?

WINT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)